iTherX

About:

iTherX is a clinical stage pharmaceutical company focused on discovering and developing treatments for Hepatitis C.

Website: http://www.itxpharma.com

Description:

iTherX is a clinical stage pharmaceutical company focused on the discovery and development of innovative treatments for Hepatitis C. This is a disease that affects almost 3% of the world's population, and is the major cause of chronic liver disease, cirrhosis, liver failure and primary liver cancer. Currently there is only a single mode of therapy and less than 5% of patients can be successfully treated.

Total Funding Amount:

$5.95M

Headquarters Location:

San Diego, California, United States

Founded Date:

1992-01-01

Contact Email:

info(AT)itherx.com

Founders:

Tsvi Goldenberg

Number of Employees:

1-10

Last Funding Date:

2011-11-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai